Description of Lipid Lowering Drugs – PST04211 Basic Pharmacology

NTA Level 4 • Semester 2 • PST04211

Description of Lipid Lowering Drugs

Basic Pharmacology • Source Session/Topic 31
Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability.

Session 31: Description of Lipid Lowering Drugs

Total Session Time: 60 minutes

Prerequisites

• None

Learning Tasks

By the end of this session students are expected to be able to:

• List indications of lipid lowering drugs
• List contraindications of lipid lowering drugs
• Describe dose, dosage and course of lipid lowering drugs
• List side effects and adverse effects of lipid lowering drugs
• Describe interactions and precautions of lipid lowering drugs

Resources Needed:

• Flip charts, marker pens, and masking tape
• Black/white board and chalk/whiteboard markers
• Overhead projector and computer

SESSION OVERVIEW

Activity/

Step Time Content

Method

1 05 minutes Presentation Introduction, Learning tasks

Presentation/

2 10 minutes Indications of Lipid Lowering Drugs

Buzzing

Presentation/

3 10 minutes Contraindications of Lipid Lowering Drugs

Brainstorming

Dose, Dosage and Course of Lipid Lowering

4 10 minutes Presentation

Drugs

Presentation/ Side Effects and Adverse Effects of Lipid

5 10 minutes

Brainstorming Lowering Drugs

Interactions and Precautions of Lipid

6 05 minutes Presentation

Lowering Drugs

7 05 minutes Presentation Key Points

8 05 minutes Presentation Evaluation

PST 04211 Basic Pharmacology NTA Level 4 Semester 2 Facilitator Guide

193

SESSION CONTENTS

STEP 1: Presentation of Session Title and Learning Tasks (5 minutes)

READ or ASK students to read the learning tasks and clarify

ASK students if they have any questions before continuing.

STEP 2: Indications of Lipid Lowering Drugs (10minutes)

Activity: Buzzing (5 minutes)

ASK students to pair up and buzz on the following question for 2 minutes

• What lipid lowering drugs are used in clinical practice?
• What are the indications of lipid lowering drugs?

ALLOW few pairs to respond and let other pairs to add on points not mentioned

WRITE their response on the flip chart/board

CLARIFY and SUMMARIZE by using the content below

• Lipid Lowering drugs include simvastatin and atovastatin which are in a group of statins

used in lowering cholesterol level in blood

• Statins are group of lipid lowering drugs
• Lipid lowering drugs are indicated in patients with:

o Primary hypercholesterolemia

o Homozygous familial hypercholesterolemia

o Combined (mixed) hyperlipidemia in patients who have not responded adequately to

diet and other appropriate measures

o Prevention of cardiovascular events in patients with atherosclerotic cardiovascular

disease or diabetes mellitus

STEP 3: Contraindications of Lipid Lowering Drugs (10 minutes)

Activity: Brainstorming (5 minutes)

Ask students to brainstorm on the following question:

What are contraindications of lipid lowering drugs?

ALLOW few students to respond

WRITE their responses on the flip chart/ board

CLARIFY and SUMMARISE by using the content below

PST 04211 Basic Pharmacology NTA Level 4 Semester 2 Facilitator Guide

194

• Lipid lowering drugs are contraindicated in patients with :

o Active liver disease

o Persistently abnormal liver function tests

o In pregnancy (adequate contraception required during treatment and for 1 month

afterwards)

o Who are breast-feeding

STEP 4: Dose, Dosage and Course of Lipid Lowering Drugs (10 minutes)

Dose of Simvastatin

• Primary hypercholesterolemia, combined hyperlipidemia, 10–20 mg daily at night,
adjusted at intervals of at least 4 weeks; usual range 10–80 mg once daily at night
• Homozygous familial hypercholesterolemia, 40 mg daily at night or 80 mg daily in 3

divided doses (with largest dose at night)

• Prevention of cardiovascular events, initially 20–40 mg once daily at night adjusted at
intervals of at least 4 weeks; max 80 mg once daily at night

STEP 5: Side Effects and Adverse Effects of Lipid Lowering Drugs (10

minutes)

Activity: Brainstorming (5 minutes)

Ask students to brainstorm on the following question:

What are the side effects and adverse effects of lipid lowering drugs?

ALLOW few students to respond

WRITE their responses on the flip chart/ board

CLARIFY and SUMMARISE by using the content below

• Side effects of simvastatin are:

o Constipation is common,

o Diarrhoea

o Nausea, vomiting

o Gastro-intestinal discomfort

o Hypertriglyceridaemia may be aggravated

o An increased bleeding tendency has been reported due to hypoprothrombinemia

associated with vitamin K deficiency

PST 04211 Basic Pharmacology NTA Level 4 Semester 2 Facilitator Guide

195

STEP 6: Interactions and Precautions of Lipid Lowering Drugs (5minutes)

• Precautions:

o Bile acid sequestrates interfere with the absorption of fat-soluble vitamins; supplements

of vitamins A, D, and K may be required when treatment is prolonged

Step 7: Key Points (5minutes)

• Lipid lowering are indicated in hypercholesterolemia, hyperlipidemia and in prevention

of cardiac events in patients with cardiac diseases and in diabetic patients

• Lipid lowering are contraindicated in liver failure, pregnancy and during breast feeding
• The side effects of lipid lowering drugs are nausea, vomiting ,constipation and abnormal

bleeding

• Dose of simvastatin ranges from 10-80mg once a day
• When using lipid lowering drugs caution as it interfere with absorption of fat soluble

vitamins

STEP 8: Evaluation (5minutes)

• What are the indications of lipid lowering drugs?
• What are the contraindications of lipid lowering drugs?
• What are the dose, dosage and course of lipid lowering drugs?
• What are side effects and adverse effects of lipid lowering drugs?
• What are the interactions and precautions of lipid lowering drug?

PST 04211 Basic Pharmacology NTA Level 4 Semester 2 Facilitator Guide

196

References

Ministry Of Health and Social Welfare. (2013). Standard Treatment Guidelines &

National Essential Medicines List Tanzania Mainland (4th ed.). Dar es salaam,

Tanzania government printers.

Robert, L. T., Gary, C.Y., Gary, R.M, Barbara, G.W., Michael, L. (2014).

Pharmacotherapy: A Pathophysiologic Approach (9th ed.). New York, McGraw-Hill

Education.

Sally S.R, & Jeanne C.S. (2000). Introductory Clinical Pharmacology (6th ed)

New York, Lippincott Williams and Wilkins.

School of Pharmaceutical sciences. (2011). Tanzania Pharmaceutical Handbook (2nd ed.).

Dar es Salaam, ARDHI University press.

The Royal Pharmaceutical Society of Great Britain. (2007). Martindale: The Extra

Pharmacopoeia (5TH ed). London, pharmaceutical press.

The Royal Pharmaceutical Society of Great Britain. (2009). British National

Formulary (59th ed). London, BMJ Group and RPS Publishing.

PST 04211 Basic Pharmacology NTA Level 4 Semester 2 Facilitator Guide

197

PDF / OFFLINE NOTES

Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP

WhatsApp: 255620339260
banner
Scroll to Top